Untargeted metabolomics demonstrates significant metabolomic differences in Physalis pubescens varieties, indicating implications for quality control and breeding programs.
Physalis pubescens L. is a nutritious fruit with recognized pharmacological value, yet its comprehensive metabolomic profile remains unexplored. This study aimed to investigate the metabolomic differences among three distinct varieties of P . pubescens , with a focus on the influence of fruit size. An untargeted metabolomics approach employing UPLC-ESI-MS/MS was utilized. Multivariate statistical analyses, including PCA and PLS-DA, revealed a clear separation in metabolic profiles, primarily driven by fruit size. Comparative analysis between large-fruited variety B and small-fruited varieties S and T identified 67 significant differential metabolites. Notably, the flavonoid quercetin was not detected in large-fruited variety B under our analytical conditions, and the relative content of most phenylpropanoid metabolites was significantly lower in large-fruited variety compared to small-fruited varieties. Conversely, 17 metabolites, including certain amino acids and riboflavin, were up-regulated in large-fruited variety. Pathway analysis highlighted riboflavin metabolism as a key distinguishing pathway. Our findings demonstrate that fruit size may be a major factor influencing the phytochemical composition of P. pubescens . The novelty of this work lies in establishing fruit size as a major factor shaping the phytochemical composition of P. pubescens . These findings provide a metabolic foundation for selecting varieties with desired nutraceutical properties and for guiding future quality control and breeding programs.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: